Survey of colorectal cancer screening practices in a large Canadian urban centre

Canadian Journal of Surgery

Volumn 47, Issue 3, 2004, Pages 189-194

  Mack, Lloyd A ^a,b   Stuart, Heather ^a   Temple, Walley J ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b TOM BAKER CANCER CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; CANADA; CANCER SCREENING; COLONOSCOPY; COLORECTAL CANCER; EVIDENCE BASED MEDICINE; FAMILY HISTORY; FEMALE; FREQUENCY ANALYSIS; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OCCULT BLOOD; POPULATION RESEARCH; PRACTICE GUIDELINE; REVIEW; URBAN AREA; AGE; ARTICLE; BLOOD; CLINICAL PRACTICE; COLORECTAL TUMOR; GENETIC PREDISPOSITION; GENETICS; HOSPITAL; MASS SCREENING; METHODOLOGY; MIDDLE AGED; QUESTIONNAIRE; RISK FACTOR; STATISTICS; UTILIZATION REVIEW;

ADULT; AGE FACTORS; AGED; CANADA; COLONOSCOPY; COLORECTAL NEOPLASMS; GENETIC PREDISPOSITION TO DISEASE; HOSPITALS, URBAN; HUMANS; MASS SCREENING; MIDDLE AGED; OCCULT BLOOD; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES; RISK FACTORS;

EID: 4344627796     PISSN: 0008428X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. National Cancer Institute of Canada. Canadian Cancer Statistics. 2001. Toronto: the Institute; 2001.
2. Winawer SJ, Zauber AG, Ho MN, O'Brien MJ, Gottlieb LS, Sternberg SS, et al. Prevention of colorectal cancer by colonoscopic polypectomy. N Engl J Med 1993;329:1977-81.
3. Mandel JS, Church TR, Ederer F, Bond JH. Colorectal cancer mortality: effectiveness of biennial screening for fecal occult blood. J Natl Cancer Inst 1999;91:434-7.
4. Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomised study of screening for colorectal cancer with fæcal-occult-blood test. Lancet 1996;348: 1467-71.
5. Hardcastle JD, Thomas WM, Chamberlain J, Pye G, Sheffield J, James PD, et al. Randomised, controlled trial of fæcal occult blood screening for colorectal cancer. Results for first 107 349 subjects. Lancet 1989;1:1160-4.
6. Kewenter J, Bjork S, Haglind E, Smith L, Svanvik J, Ahren C. Screening and rescreening for colorectal cancer: a controlled trial of fecal occult blood testing in 27 700 subjects. Cancer 1988;62:645-51.
7. Cummings SM, Savitz LA, Konrad TR. Reported response rates to mailed physician questionnaires. Health Serv Res 2001; 35:1347-55.
8. Asch DA, Jedrziewski MK, Cristakis NA. Response rates to mail surveys published in medical journals. J Clin Epidemiol 1997; 50:1129-36.
9. Field TS, Cadoret CA, Brown ML, Ford M, Greene SM, Hill D, et al. Surveying physicians: Do components of the "total design approach" to optimizing survey response rates apply to physicians? Med Care 2002;40:596-605.
10. Dillman DA. Mail and internet surveys: the tailored design method. New York: John Wiley and Sons; 1999.
11. Mcleod R, with the Canadian Task Force on Preventive Health Care. Screening strategies for colorectal cancer: systematic review and recommendations. London ON: the task force; 2001.
12. Hawley ST, Levin B, Vernon SW. Colorectal cancer screening by primary care physicians in two medical care organizations. Cancer Detect Prev 2001;25:309-18.
13. Center for Disease Control. Trends in screening for colorectal cancer - United States, 1997 and 1999. MMWR Morb Mortal Wkly Rep 2001;50:162-6.
14. Ruffin MT, Gorenflo DW, Woodman B. Predictors of screening for breast, cervical, colorectal, and prostatic cancer among community-based primary care practices. J Am Fam Pract 2000;13:1-10.
15. Battista RN, Palmer CS, Marchand BM, Spitzer WO. Patterns of preventive practice in New Brunswick. CMAJ 1985;132: 1013-5.
16. Towler B, Irwig L, Glasziou P, Kewenter J, Weller D, Silagy C. A systematic review of the effects of screening for colorectal cancer using the fæcal occult blood test, hemoccult. BMJ1998;317:559-65.
17. Friedman GD, Collen MF, Fireman BH. Multiphasic health checkup evaluation: a 16-year follow-up. J Chronic Dis 1986;39: 453-63.
18. Newcomb PA, Norfleet RG, Storer BE, Surawicz TS, Marcus PM. Screening sigmoidoscopy and colorectal cancer mortality. J Natl Cancer Inst 1992;84:1572-5.
19. Selby JV, Friedman GD, Quesenberry CP Jr, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653-7.
20. Baker JW, Gathright JB Jr, Timmcke AE, Hicks TC, Ferrari BT, Ray JE. Colonoscopic screening of asymptomatic patients with a family history of colon cancer. Dis Colon Rectum 1990;33:926-30.
21. Syrigos KN, Charalampopoulos A, Ho JL, Zbar A, Murday VA, Leicester RJ. Colonoscopy in asymptomatic individuals with a family history of colorectal cancer. Ann Surg Oncol 2002;9:439-43.
22. Winawer SJ, Fletcher RH, Miller L, Godlee F, Stolar MH, Mulrow CD, et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997;112: 594-642.
23. Imperiale TF, Wagner DR, Lin CY, Larkin GN, Rogge JD, Ransohoff DF. Risk of advanced proximal neoplasms in asymptomatic adults according to the distal colorectal findings. N Engl J Med 2000;343:169-74.
24. Liberman DA, Weiss DG, Bond JH, Ahnen DJ, Garewal H, Chejfec G. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000; 343:162-8.
25. Winawer ST, Stewart ET, Zauber AG, Bond JH, Ansel H, Waye JD, et al. A comparison of colonoscopy and double-contrast barium enema for surveillance after polypectomy. N Engl J Med 2000; 342:1766-72.
26. US Preventive Services Task Force. Screening for colorectal cancer: recommendation and rationale. Ann Intern Med 2002;133: 573-84.
27. Simmang CL, Senatore P, Lowry A, Hicks T, Burnstein M, Dentsman F, et al. Practice parameters for the detection of colorectal neoplasms. The Standards Committee, The American Society of Colon and Rectal Surgeons. Dis Colon Rectum 1999; 42:1123-9.
28. Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberger D, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal and endometrial cancers. CA Cancer J Clin 2001;51:38-75.
29. Read TE, Kodner IJ. Colorectal cancer: risk factors and recommendations for early detection. Am Fam Phys 1999;59:3083.
30. Nelson DB, McQuaid KR, Bond JH, Lieberman DA, Weiss DG, Johnston TK. Procedural success and complications of large-scale screening colonoscopy. Gastrointest Endosc 2002;55:307-14.
31. Podolsky DK. Going the distance - the case for true colorectal-cancer screening. N Engl J Med 2000;343:207-8.
32. Garbay JK, Suc B, Rotman N, Fourtanier G, Escat J. Mulicentre study of surgical complications of colonscopy. Br J Surg 1996;83:42-4.
33. Liberman DA, Weiss DG. One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon. N Engl J Med 2001;345:555-60.
34. Frazier AL, Colditz GA, Fuchs CS, Kuntz KM. Cost-effectiveness of screening for colorectal cancer in the general population. JAMA 2000;284:1954-61.
35. Khandker RK, Dulski JD, Kilpatrick JB, Ellis RP, Mitchell JB, Baine WB. A decision model and cost-effectiveness analysis of colorectal cancer screening and suveillance guidelines for average-risk adults. Int J Technol Assess Health Care 2000;16: 799-810.
36. Sonnenberg A, Delco F, Inadomi JM. Cost-effectiveness of colonoscopy in screening for colorectal cancer. Ann Intern Med 2000;137:129-31.